The 2023 Psychedelic Industry Landscape with Psychedelic Alpha
Business Trip by PsyMed Ventures, a podcast about the business of psychedelics
Welcome back to Business Trip by PsyMed Ventures, a podcast about the business of psychedelics! 🍄
In this week’s episode, Greg and Matias chat with Josh Hardman, the founder of Psychedelic Alpha.
Josh is a leading writer and founder at Psychedelic Alpha, an online resource, newsletter, and community covering the intersection of psychedelics and business. He regularly collaborates and writes with experts in the psychedelic field including entrepreneurs, academic researchers, non-profits, and more to provide a comprehensive understanding of the latest developments in the industry. Psychedelic Alpha recently released Psychedelics 2022: A Year in Review to comment on and analyze the industry across research, funding, and policy.
In this episode, we discuss:
The growth of the psychedelic market in 2022 into 2023
Paths to commercialization for MAPS and Compass Pathways
The impact of state legislation on psychedelic biotech
A 2023 outlook for fundraising and job opportunities
Listen to the episode here, on Spotify or Apple Podcasts.
When you’re done listening, tweet at us @psymedventures to share your thoughts!
P.S. If know someone who would like Business Trip? Feel free to share the newsletter by clicking the link below and hitting the ❤️ button on this post so more people can discover it on Substack 🙏
Business Trip by PsyMed Ventures is a podcast about psychedelic startups. Each episode features a new company in the field, ranging from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem.
Business Trip is produced by Greg Kubin and Matias Serebrinsky — we’re partners at PsyMed Ventures, advocates of the healing powers of psychedelic medicine.
Thanks for listening,